Lily Boo
Overview
Explore the profile of Lily Boo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
139
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Koh M, Ho W, Yeap S, Ali N, Yong C, Boo L, et al.
Pathol Res Pract
. 2022 Apr;
233:153854.
PMID: 35398617
Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype with higher risk of metastasis and cancer reoccurrence. Cisplatin is one of the potential anticancer drugs for treating...
2.
Koh M, Ho W, Yeap S, Ali N, Boo L, Alitheen N
Pharmaceuticals (Basel)
. 2021 Apr;
14(5).
PMID: 33919109
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that promotes a higher risk of metastasis and cancer reoccurrence. Cisplatin is one of the potential anticancer drugs for treating...
3.
Yeap S, Ali N, Akhtar M, Razak N, Chong Z, Ho W, et al.
Molecules
. 2021 Mar;
26(5).
PMID: 33652854
(2,6)-2,6--(4-hydroxy-3-methoxybenzylidene)-cyclohexanone (BHMC) is a synthetic curcumin analogue, which has been reported to possess anti-tumor, anti-metastatic, and anti-invasion properties on estrogen receptor (ER) negative breast cancer cells in vitro and in...
4.
Ali N, Yeap S, Ho W, Boo L, Ky H, Satharasinghe D, et al.
Pharmaceuticals (Basel)
. 2020 Dec;
14(1).
PMID: 33374139
Globally, breast cancer is the most frequently diagnosed cancer in women, and it remains a substantial clinical challenge due to cancer relapse. The presence of a subpopulation of dormant breast...
5.
Boo L, Yeap S, Ali N, Ho W, Ky H, Satharasinghe D, et al.
J Chin Med Assoc
. 2020 Jan;
83(1):67-76.
PMID: 31904742
Background: In vitro 3-dimensional (3D) spheroid culture has been widely used as model to enrich CD44CD24 cancer stem cells (CSC) with high aldehyde dehydrogenase 1 (ALDH1) activity. Although CD24 subpopulation...
6.
Boo L, Ho W, Ali N, Yeap S, Ky H, Chan K, et al.
PeerJ
. 2017 Jul;
5:e3551.
PMID: 28717596
Breast cancer spheroids have been widely used as models of cancer stem cells (CSCs), yet little is known about their phenotypic characteristics and microRNAs (miRNAs) expression profiles. The objectives of...
7.
Boo L, Ho W, Ali N, Yeap S, Ky H, Chan K, et al.
Int J Biol Sci
. 2016 Mar;
12(4):427-45.
PMID: 27019627
Breast cancer is the second leading cause of cancer-related mortality worldwide as most patients often suffer cancer relapse. The reason is often attributed to the presence of cancer stem cells...
8.
Ali N, Boo L, Yeap S, Ky H, Satharasinghe D, Liew W, et al.
PeerJ
. 2016 Jan;
4:e1536.
PMID: 26788424
Decline in the therapeutic potential of bone marrow-derived mesenchymal stem cells (MSC) is often seen with older donors as compared to young. Although hypoxia is known as an approach to...
9.
Boo L, Selvaratnam L, Tai C, Ahmad T, Kamarul T
J Mater Sci Mater Med
. 2011 Apr;
22(5):1343-56.
PMID: 21461701
The use of mesenchymal stem cells (MSCs) in tissue repair and regeneration despite their multipotentiality has been limited by their cell source quantity and decelerating proliferative yield efficiency. A study...